GGrantIndex
Sort

50,496 grants matching lung cancer

A smoke-free home intervention in federally subsidized housing

$681,194
Maya Vijayaraghavan · University Of California, San Francisco · R01 · FY2025 · MD

MATCHMAKERS - Creating and training AI tools for TCR binding prediction and design

$681,176
Michael Birnbaum · Massachusetts Institute Of Technology · OT2 · FY2024 · CA

Genetic Susceptibility to Lung Cancer

$681,057
David C Christiani · Harvard School Of Public Health · R01 · FY2008 · CA

Radiation-induced translational control of gene expression

$681,047
Philip Tofilon · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA

Development and Translation of Advanced Motion Correction Technologies for Cardiac PET/CT

$680,943
Chi Liu · Yale University · R01 · FY2024 · HL

Analyses of human T regulatory cells

$680,834
Kwong Yok Tsang · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA

Identification of human tumor-associated antigens

$680,834
Kwong Yok Tsang · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA

Detection of metastases in lymph nodes using quantitative ultrasound

$680,776
Ernest Joseph Feleppa · Riverside Research Institute · R01 · FY2017 · CA

Endothelial Cell-Targeted Amatoxin Conjugates for Effective Therapy of Breast Cancer

$680,774
Bogdan Olenyuk · Proteogenomics Research Instit/Sys/ Med · R01 · FY2023 · CA

Development of 3D Alveolar Tissue Models, CRISPR-editing and Microbiota-immune Response Assay Platforms for Deciphering Human Lung Immunity

$680,574
Derya Unutmaz · Jackson Laboratory · U19 · FY2019 · AI

Faith-Based Approaches in the Treatment of Hypertension (FAITH)

$680,528
Gbenga Godwin Ogedegbe · New York University School Of Medicine · R01 · FY2011 · HL

Elucidate the landscape of druggable targets for eliminating cancer persister cells

$680,507
Steven J Altschuler · University Of California, San Francisco · R01 · FY2025 · CA

Improving the Human Reference Genome Resource

$680,505
Richard K. Wilson · Washington University · U41 · FY2016 · HG

Dissecting the hematopoietic pathways governing age-associated pathogenic myelopoiesis

$680,334
Miriam Merad · Icahn School Of Medicine At Mount Sinai · R01 · FY2025 · CA

Integrating Tobacco Treatment into Cancer Care

$680,316
Elyse R Park · Massachusetts General Hospital · R01 · FY2014 · CA

Proteomic Profiling of Idiopathic Pulmonary Fibrosis Progression Trajectory

$680,289
Justin M Oldham · University Of Michigan At Ann Arbor · R01 · FY2024 · HL

Canadian Fluoroscopy Cohort Study: Lifespan Mortality and Incidence Follow-Up

$680,242
Lydia B Zablotska · University Of California, San Francisco · R01 · FY2017 · CA

Administrative Core

$680,221
Fred R Hirsch · Icahn School Of Medicine At Mount Sinai · U54 · FY2020 · CA

Gene-tobacco carcinogen interactions and lung cancer risk - a novel approach for precision cancer prevention

$680,190
Philip Lazarus · State University Of New York At Buffalo · R01 · FY2025 · CA

Adaptive Interventions for Smoking Cessation in Lung Cancer Screening Programs

$680,031
Anne Joseph · University Of Minnesota · R01 · FY2019 · CA

Novel roles of RNA modifications in the pathogenesis of pulmonary vascular remodeling and PAH

$679,977
You-Yang Zhao · Lurie Children'S Hospital Of Chicago · R01 · FY2022 · HL

Investigate the role of extracellular vesicles in promoting the progression of pulmonary lymphangioleiomyomatosis

$679,938
Magdalena Karbowniczek · Texas Tech University Health Scis Center · R01 · FY2024 · HL

(PQB4) Age-cancer interplay of genome and epi-genome in human lung

$679,887
Jan No Middle Name Vijg · Albert Einstein College Of Medicine · R01 · FY2014 · CA

Quantitative Low-Dose PET Imaging

$679,852
Chi Liu · Yale University · R01 · FY2020 · EB

Quantitative Low-Dose PET Imaging

$679,852
Chi Liu · Yale University · R01 · FY2019 · EB